Seeing Is Believing
Currently out of the existing stock ratings of Kevin Ellich, 15 are a BUY (34.88%), 24 are a HOLD (55.81%), 4 are a SELL (9.3%).
Analyst Kevin Ellich, carries an average stock price target met ratio of 100% that have a potential upside of 14.66% achieved within 333 days. Previously, Kevin Ellich worked at CRAIG HALLUM, PIPER SANDLER.
Kevin Ellich’s has documented 106 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on AMED, Amedisys at 31-Oct-2019.
Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for PETS (PETMED EXPRESS) at 10/17/2019. The price target of $20 was fulfilled within 4 days with a profit of $3.63 (22.17%) receiving and performance score of 55.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$100
$-0.99 (-0.98%)
$100
5 months 26 days ago
(16-Apr-2025)
2/3 (66.67%)
$8.09 (8.80%)
307
Hold
$101
$0.01 (0.01%)
$103
7 months 8 days ago
(03-Mar-2025)
4/11 (36.36%)
$8.9 (9.66%)
18
Hold
$101
$0.01 (0.01%)
$165
1 years 2 months 11 days ago
(31-Jul-2024)
3/9 (33.33%)
$2.95 (3.01%)
70
Hold
$101
$0.01 (0.01%)
$101
1 years 2 months 17 days ago
(25-Jul-2024)
2/7 (28.57%)
$3.25 (3.32%)
419
Hold
1 years 6 months 16 days ago
(26-Mar-2024)
5/9 (55.56%)
$12.13 (9.49%)
99
What Year was the first public recommendation made by Kevin Ellich?